Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aidi injection combined with paclitaxel-containing chemotherapy pharmacokinetic interaction study in non-small cell lung cancer
ChiCTR2000029106Phase 2Completed
- Sponsor
- Cancer Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of aidi injection and paclitaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Cancer Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Paclitaxel exposure. Started Jun 2015; status: completed.
02
Drugs
aidi injectionpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2000029106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029106.